Driven by the urgent need to address off-target toxicity-related concerns and improve therapeutic outcomes of biologic drugs, several patient-centric medical devices that facilitate drug delivery to desired physiological regions, are being developed

Roots Analysis has announced the addition of “Organ–based / Targeted Drug Delivery Devices Market for Biologics (Intra-organ / Intra-tumoral), 2020 – 2030” report to its list of offerings.

Leave a Reply

Your email address will not be published. Required fields are marked *